77 related articles for article (PubMed ID: 26308232)
21. Prechemotherapy Hemoglobin Levels as a Predictive Factor of Ovarian Cancer Survival: A Systematic Review and Meta-Analysis.
Pergialiotis V; Daskalakis G; Thomakos N; Bellos I; Haidopoulos D; Loutradis D; Rodolakis A
Am J Clin Oncol; 2019 Sep; 42(9):725-731. PubMed ID: 31361606
[TBL] [Abstract][Full Text] [Related]
22. Hormone Replacement Therapy in Endometrial Cancer Survivors: A Meta-Analysis.
Londero AP; Parisi N; Tassi A; Bertozzi S; Cagnacci A
J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300331
[TBL] [Abstract][Full Text] [Related]
23. Vaginal Misoprostol for Overcoming Inadequate Colposcopies: A Meta-analysis of Randomized Controlled Trials.
Pergialiotis V; Vlachos DE; Pitsouni E; Perrea D; Vlachos GD
J Low Genit Tract Dis; 2015 Jul; 19(3):257-61. PubMed ID: 25023333
[TBL] [Abstract][Full Text] [Related]
24. Mortality associated with hormone replacement therapy in younger and older women.
Salpeter S
J Gen Intern Med; 2006 Apr; 21(4):401. PubMed ID: 16686828
[No Abstract] [Full Text] [Related]
25. Beating the odds: molecular characteristics of long-term survivors of ovarian cancer.
Nat Genet; 2022 Dec; 54(12):1780-1781. PubMed ID: 36456882
[No Abstract] [Full Text] [Related]
26. Comment on "Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis".
Nie W; Ding H; Zou X
Breast Cancer Res Treat; 2022 May; 193(1):237-238. PubMed ID: 35175430
[No Abstract] [Full Text] [Related]
27. Hormone therapy and ovarian cancer.
Trémollieres F; Lopès P; Gompel A;
Lancet; 2015 Sep; 386(9998):1038. PubMed ID: 26382992
[No Abstract] [Full Text] [Related]
28. Hormone therapy and ovarian cancer - Authors' reply.
Beral V; Hermon C; Peto R; Reeves G;
Lancet; 2015 Sep; 386(9998):1038-9. PubMed ID: 26382993
[No Abstract] [Full Text] [Related]
29. Hormone replacement therapy after surgery for epithelial ovarian cancer.
Saeaib N; Peeyananjarassri K; Liabsuetrakul T; Buhachat R; Myriokefalitaki E
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012559. PubMed ID: 31989588
[TBL] [Abstract][Full Text] [Related]
30. Parity and endometrial cancer risk: a meta-analysis of epidemiological studies.
Wu QJ; Li YY; Tu C; Zhu J; Qian KQ; Feng TB; Li C; Wu L; Ma XX
Sci Rep; 2015 Sep; 5():14243. PubMed ID: 26373341
[TBL] [Abstract][Full Text] [Related]
31. Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers.
Altman AD; Ferguson SE; Atenafu EG; Köbel M; McAlpine JN; Panzarella T; Lau S; Gien LT; Gilks B; Clarke B; Cameron A; Nelson G; Han G; Samouëlian V; Ho TC; Louie K; Bernardini MQ
Gynecol Oncol; 2015 Nov; 139(2):268-74. PubMed ID: 26352641
[TBL] [Abstract][Full Text] [Related]
32. Menopause and the Heart.
Nkonde-Price C; Bender JR
Endocrinol Metab Clin North Am; 2015 Sep; 44(3):559-64. PubMed ID: 26316243
[TBL] [Abstract][Full Text] [Related]
33. Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis Study.
Shufelt C; Elboudwarej O; Johnson BD; Mehta P; Bittner V; Braunstein G; Berga S; Stanczyk F; Dwyer K; Merz CN
Menopause; 2016 Feb; 23(2):150-7. PubMed ID: 26308234
[TBL] [Abstract][Full Text] [Related]
34. Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.
Deli T; Orosz M; Jakab A
Pathol Oncol Res; 2020 Jan; 26(1):63-78. PubMed ID: 30617760
[TBL] [Abstract][Full Text] [Related]
35. Hormone therapy and risk of ovarian cancer in postmenopausal women: a systematic review and meta-analysis.
Shi LF; Wu Y; Li CY
Menopause; 2016 Apr; 23(4):417-24. PubMed ID: 26506499
[TBL] [Abstract][Full Text] [Related]
36. Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.
Palaia I; Caruso G; Di Donato V; Turetta C; Savarese A; Perniola G; Gallo R; Giannini A; Salutari V; Bogani G; Tomao F; Giannarelli D; Gentile G; Musella A; Muzii L; Pignata S;
J Gynecol Oncol; 2024 May; 35(3):e70. PubMed ID: 38497108
[TBL] [Abstract][Full Text] [Related]
37. Impact of Hormone Replacement Therapy on the Overall Survival and Progression Free Survival of Ovarian Cancer Patients: A Systematic Review and Meta-Analysis.
Achimaș-Cadariu PA; Păun DL; Pașca A
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672307
[TBL] [Abstract][Full Text] [Related]
38. Using menopausal hormone therapy after a cancer diagnosis in Ireland.
Donohoe F; O'Meara Y; Roberts A; Comerford L; Kelly CM; Walshe JM; Lundy D; Hickey M; Brennan DJ
Ir J Med Sci; 2023 Feb; 192(1):45-55. PubMed ID: 35141870
[TBL] [Abstract][Full Text] [Related]
39. An Italian National Survey on Ovarian Cancer Treatment at first diagnosis. There's None so Deaf as those who will not Hear.
Mandato VD; Torricelli F; Uccella S; Pirillo D; Ciarlini G; Ruffo G; Annunziata G; Manzotti G; Pignata S; Aguzzoli L
J Cancer; 2021; 12(15):4443-4454. PubMed ID: 34149908
[No Abstract] [Full Text] [Related]
40. Psychosexual morbidity in women with ovarian cancer.
Logue CA; Pugh J; Jayson G
Int J Gynecol Cancer; 2020 Dec; 30(12):1983-1989. PubMed ID: 33115791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
